Additional file 1: Table S1. of Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

2018 
Treatment costs according to type of first-line treatment received by patients with EGFR Mutâ +â NSCLC. (DOCX 15 kb)
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []